best time of day to inject tirzepatide and for GLP-1 Injections Explained TrimRX | What Time of
Description
Purpose of Review This review explores the evolving role of anti-obesity medications (AOMs) in managing cardiovascular (CV) risk among individuals with overweight and obesity

** NRV: Nutrient reference values according to the Food Information Regulation
Conclusions Consistent with clinical trials, real-world tirzepatide treatment was associated with greater 6-month weight reduction and more frequent achievement of weight-reduction targets and improvements in select cardiometabolic parameters than semaglutide among adults with obesity without diabetes

Retatrutide is a novel triple agonist of glucose-dependent insulinotropic polypeptide, glucagon-like peptide 1 and glucagon receptor

Lilly posted explosive 54% revenue growth powered by its GLP-1 obesity and diabetes drugs

But you should not use the same spot for both injections
